GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment
暂无分享，去创建一个
Robert H Bates | N. Fotouhi | G. Besra | J. Lelièvre | David Barros | G. Robertson | N. Cammack | H. Boshoff | Katherine A Abrahams | P. Converse | S. Tyagi | K. Mdluli | E. Nuermberger | Lluís Ballell | Esther Pérez-Herrán | Si-yang Li | J. Esquivias | A. Upton | María S Martínez-Martínez | R. Tasneen | Beatriz Urones | E. Jiménez | O. Sanz | G. Boyle | H. Soni | G. Maher-Edwards | S. Turner | Juan Miguel Siles | Marta Alonso | J. Escribano | Joaquin Rullas-Trincado | Gareth Maher-Edwards